サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1771560

大分子創薬アウトソーシング市場規模、シェア、動向分析レポート：ワークフロー別、サービス別、治療領域別、最終用途別、地域別、セグメント別予測、2025年～2030年

Large Molecule Drug Discovery Outsourcing Market Size, Share & Trends Analysis Report By Workflow, By Service, By Therapeutics Area, By End-use, By Region, And Segment Forecasts, 2025 - 2030

出版日
ページ情報
英文 120 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=147.48円
大分子創薬アウトソーシング市場規模、シェア、動向分析レポート：ワークフロー別、サービス別、治療領域別、最終用途別、地域別、セグメント別予測、2025年～2030年
出版日: 2025年06月10日
発行: Grand View Research
ページ情報: 英文 120 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

大分子医薬品創薬アウトソーシング市場のサマリー

世界の大分子医薬品創薬アウトソーシング市場規模は、2024年に28億9,000万米ドルと推計され、2025年から2030年にかけてCAGR 9.02%で成長し、2030年には48億3,000万米ドルに達すると予測されます。市場を牽引しているのは、生物製剤と次世代治療薬に対する需要の高まりです。

製薬会社は、生物学的製剤に対する需要の高まりを受けて、低分子化合物からペプチド、組み換えタンパク質、遺伝子改変剤などの大型生体分子化合物へのシフトを強めています。その結果、医薬品スポンサーは、こうした生物製剤に特化した創薬を専門とする開発業務受託機関（CRO）のサービスを積極的に求めるようになっています。この動向により、バイオアッセイ開発、構造生物学、機能性スクリーニングなどの分野で、初期段階の科学的協力や専門知識を重視するアウトソーシング戦略が台頭しています。

さらに、新たな動向として、バイオ製薬企業とCROの戦略的提携が注目されており、革新的なプラットフォームベースのモデルに重点を置くことで、研究開発リスクを軽減しながら資産の進捗を高める役割を果たしています。さらに、アウトソーシングサービスの需要は、科学的専門知識の深さ、費用対効果、治療領域の専門性により影響を受ける。このため、神経変性疾患、希少疾患、自己免疫疾患に強い関心を持つパートナーとの提携に対する需要が高まっています。

さらに、北米やアジア太平洋などの地域に生物製剤イノベーションの拠点を求める企業が増えており、市場の世界な拡大が状況を一変させています。さらに、CROはAI主導のツール、バイオマーカー探索プラットフォーム、自動スクリーニングプロセスを統合し、候補化合物選択の精度を高めています。このような科学的進歩、地理的成長、デジタル革新の組み合わせにより、高分子探索アウトソーシングは現代の生物製剤研究開発戦略の基本的側面として確立しつつあります。このような要因が、推定期間中の市場成長を促進すると予想されます。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 大分子医薬品創薬アウトソーシング市場の変数、動向、範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連/補助市場展望
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • 臨床試験件数分析（2024年）
    • 地域別臨床試験総数
    • フェーズ別臨床試験総数
    • 研究デザイン別臨床試験総数
    • 主要治療領域別臨床試験総数
  • 価格モデル分析
  • テクノロジー情勢
  • 市場分析ツール
    • ポーターのファイブフォース分析
    • SWOT分析によるPESTEL
    • COVID-19の影響分析

第4章 大分子医薬品創薬アウトソーシング市場：ワークフローの推定・動向分析

  • 大分子医薬品創薬アウトソーシング市場（ワークフロー別）：セグメントダッシュボード
  • 大分子医薬品創薬アウトソーシング市場（ワークフロー別）：変動分析
  • ワークフロー別、2018年～2030年
  • ターゲットの特定とスクリーニング
  • ターゲット検証と機能情報科学
  • リード特定と候補者最適化
  • 前臨床開発
  • その他

第5章 大分子医薬品創薬アウトソーシング市場：サービスの推定・動向分析

  • 大分子医薬品創薬アウトソーシング市場（サービス別）：セグメントダッシュボード
  • 大分子医薬品創薬アウトソーシング市場（サービス別）：変動分析
  • サービス別、2018年～2030年
  • 化学サービス
  • 生物学サービス

第6章 大分子医薬品創薬アウトソーシング市場：治療薬領域の推定・動向分析

  • 大分子医薬品創薬アウトソーシング市場（治療薬領域別）：セグメントダッシュボード
  • 大分子医薬品創薬アウトソーシング市場（治療薬領域別）：変動分析
  • 治療領域別、2018年～2030年
  • 呼吸器系
  • 痛みと麻酔
  • 腫瘍学
  • 眼科
  • 血液学
  • 心血管系
  • 内分泌
  • 胃腸
  • 免疫調節
  • 抗感染性
  • 中枢神経系
  • 皮膚科
  • 泌尿生殖器系

第7章 大分子医薬品創薬アウトソーシング市場：最終用途の推定・動向分析

  • 大分子医薬品創薬アウトソーシング市場（最終用途別）：セグメントダッシュボード
  • 大分子医薬品創薬アウトソーシング市場（最終用途別）：変動分析
  • 用途別、2018年～2030年
  • 製薬・バイオテクノロジー企業
  • 学術機関

第8章 大分子医薬品創薬アウトソーシング市場：地域の推定・動向分析

  • 地域市場ダッシュボード
  • 地域別市場シェア分析、2024年および2030年
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • デンマーク
    • スウェーデン
    • ノルウェー
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • タイ
    • 韓国
    • オーストラリア
  • ラテンアメリカ
    • ブラジル
    • アルゼンチン
  • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第9章 競合情勢

  • 市場参入企業の分類
  • 企業市場シェア/評価分析、2024年
  • 企業プロファイル
    • Evotec SE
    • Charles River Laboratories International, Inc.
    • WuXi AppTec
    • Laboratory Corporation of America Holdings
    • Thermo Fisher Scientific Inc.
    • Merck &Co., Inc.
    • GenScript Biotech Corporation
    • Jubilant Biosys Limited
    • Pharmaron Beijing Co., Ltd.
    • Syngene International Limited
    • Dalton Pharma Services
    • Domainex Ltd.
    • Eurofins Scientific SE
    • QIAGEN NV
    • TCG Lifesciences Pvt Ltd.
図表

List of Tables

  • Table 1. List of Secondary Sources
  • Table 2. List of Abbreviations
  • Table 3. Global Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2018 - 2030 (USD Million)
  • Table 4. Global Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 5. Global Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2018 - 2030 (USD Million)
  • Table 6. Global Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 7. Global Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Region, 2018 - 2030 (USD Million)
  • Table 8. North America Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
  • Table 9. North America Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2018 - 2030 (USD Million)
  • Table 10. North America Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 11. North America Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2018 - 2030 (USD Million)
  • Table 12. North America Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 13. U.S. Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2018 - 2030 (USD Million)
  • Table 14. U.S. Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 15. U.S. Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2018 - 2030 (USD Million)
  • Table 16. U.S. Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 17. Canada Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2018 - 2030 (USD Million)
  • Table 18. Canada Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 19. Canada Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2018 - 2030 (USD Million)
  • Table 20. Canada Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 21. Mexico Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2018 - 2030 (USD Million)
  • Table 22. Mexico Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 23. Mexico Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2018 - 2030 (USD Million)
  • Table 24. Mexico Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 25. Europe Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
  • Table 26. Europe Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2018 - 2030 (USD Million)
  • Table 27. Europe Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 28. Europe Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2018 - 2030 (USD Million)
  • Table 29. Europe Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 30. UK Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2018 - 2030 (USD Million)
  • Table 31. UK Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 32. UK Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2018 - 2030 (USD Million)
  • Table 33. UK Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 34. Germany Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2018 - 2030 (USD Million)
  • Table 35. Germany Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 36. Germany Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2018 - 2030 (USD Million)
  • Table 37. Germany Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 38. France Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2018 - 2030 (USD Million)
  • Table 39. France Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 40. France Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2018 - 2030 (USD Million)
  • Table 41. France Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 42. Italy Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2018 - 2030 (USD Million)
  • Table 43. Italy Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 44. Italy Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2018 - 2030 (USD Million)
  • Table 45. Italy Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 46. Spain Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2018 - 2030 (USD Million)
  • Table 47. Spain Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 48. Spain Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2018 - 2030 (USD Million)
  • Table 49. Spain Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 50. Denmark Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2018 - 2030 (USD Million)
  • Table 51. Denmark Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 52. Denmark Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2018 - 2030 (USD Million)
  • Table 53. Denmark Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 54. Sweden Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2018 - 2030 (USD Million)
  • Table 55. Sweden Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 56. Sweden Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2018 - 2030 (USD Million)
  • Table 57. Sweden Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 58. Norway Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2018 - 2030 (USD Million)
  • Table 59. Norway Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 60. Norway Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2018 - 2030 (USD Million)
  • Table 61. Norway Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 62. Asia Pacific Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
  • Table 63. Asia Pacific Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2018 - 2030 (USD Million)
  • Table 64. Asia Pacific Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 65. Asia Pacific Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2018 - 2030 (USD Million)
  • Table 66. Asia Pacific Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 67. Japan Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2018 - 2030 (USD Million)
  • Table 68. Japan Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 69. Japan Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2018 - 2030 (USD Million)
  • Table 70. Japan Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 71. China Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2018 - 2030 (USD Million)
  • Table 72. China Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 73. China Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2018 - 2030 (USD Million)
  • Table 74. China Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 75. India Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2018 - 2030 (USD Million)
  • Table 76. India Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 77. India Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2018 - 2030 (USD Million)
  • Table 78. India Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 79. Thailand Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2018 - 2030 (USD Million)
  • Table 80. Thailand Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 81. Thailand Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2018 - 2030 (USD Million)
  • Table 82. Thailand Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 83. South Korea Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2018 - 2030 (USD Million)
  • Table 84. South Korea Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 85. South Korea Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2018 - 2030 (USD Million)
  • Table 86. South Korea Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 87. Australia Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2018 - 2030 (USD Million)
  • Table 88. Australia Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 89. Australia Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2018 - 2030 (USD Million)
  • Table 90. Australia Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 91. Latin America Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
  • Table 92. Latin America Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2018 - 2030 (USD Million)
  • Table 93. Latin America Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 94. Latin America Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2018 - 2030 (USD Million)
  • Table 95. Latin America Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 96. Brazil Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2018 - 2030 (USD Million)
  • Table 97. Brazil Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 98. Brazil Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2018 - 2030 (USD Million)
  • Table 99. Brazil Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 100. Argentina Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2018 - 2030 (USD Million)
  • Table 101. Argentina Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 102. Argentina Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2018 - 2030 (USD Million)
  • Table 103. Argentina Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 104. Middle East & Africa Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
  • Table 105. Middle East & Africa Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2018 - 2030 (USD Million)
  • Table 106. Middle East & Africa Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 107. Middle East & Africa Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2018 - 2030 (USD Million)
  • Table 108. Middle East & Africa Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 109. South Africa Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2018 - 2030 (USD Million)
  • Table 110. South Africa Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 111. South Africa Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2018 - 2030 (USD Million)
  • Table 112. South Africa Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 113. Saudi Arabia Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2018 - 2030 (USD Million)
  • Table 114. Saudi Arabia Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 115. Saudi Arabia Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2018 - 2030 (USD Million)
  • Table 116. Saudi Arabia Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 117. UAE Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2018 - 2030 (USD Million)
  • Table 118. UAE Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 119. UAE Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2018 - 2030 (USD Million)
  • Table 120.UAE Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 121. Kuwait Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2018 - 2030 (USD Million)
  • Table 122. Kuwait Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 123. Kuwait Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2018 - 2030 (USD Million)
  • Table 124. Kuwait Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Market formulation & validation
  • Fig. 6 Commodity flow analysis
  • Fig. 7 Value-chain-based sizing & forecasting
  • Fig. 8 QFD model sizing & forecasting
  • Fig. 9 Bottom-up approach
  • Fig. 10 Market snapshot
  • Fig. 11 Segment snapshot 1
  • Fig. 12 Segment snapshot 2
  • Fig. 13 Competitive landscape snapshot
  • Fig. 14 Parent market outlook, 2024 (USD Billion)
  • Fig. 15 Ancillary market outlook, 2024 (USD Billion)
  • Fig. 16 Large Molecule Drug Discovery Outsourcing Market Dynamics
  • Fig. 17 Porter's five forces analysis
  • Fig. 18 PESTEL analysis
  • Fig. 19 Large Molecule Drug Discovery Outsourcing Market: Workflow outlook and key takeaways
  • Fig. 20 Large Molecule Drug Discovery Outsourcing Market: Workflow movement analysis
  • Fig. 21 Target Identification & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Target Validation & Functional Informatics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Lead Identification & Candidate Optimization Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Preclinical Development Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Other Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Large Molecule Drug Discovery Outsourcing Market: Service outlook and key takeaways
  • Fig. 27 Large Molecule Drug Discovery Outsourcing Market: Service movement analysis
  • Fig. 28 Chemistry Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 Biology Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Large Molecule Drug Discovery Outsourcing Market: Therapeutics Area outlook and key takeaways
  • Fig. 31 Large Molecule Drug Discovery Outsourcing Market: Therapeutics Area movement analysis
  • Fig. 32 Respiratory system Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Pain and Anesthesia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Oncology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Ophthalmology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Hematology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Cardiovascular Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Endocrine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Gastrointestinal Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Immunomodulation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Anti-infective Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Central Nervous System Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Dermatology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Genitourinary System Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Large Molecule Drug Discovery Outsourcing Market: End Use outlook and key takeaways
  • Fig. 46 Large Molecule Drug Discovery Outsourcing Market: End Use movement analysis
  • Fig. 47 Pharmaceutical & Biotechnology companies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Academic Institutes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Regional Marketplace: Key Takeaways
  • Fig. 50 North America Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Key country dynamics
  • Fig. 52 U.S. Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Key country dynamics
  • Fig. 54 Canada Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Key country dynamics
  • Fig. 56 Mexico Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Europe Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Key country dynamics
  • Fig. 59 UK Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Key country dynamics
  • Fig. 61 Germany Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 Key country dynamics
  • Fig. 63 France Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 Key country dynamics
  • Fig. 65 Italy Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 Key country dynamics
  • Fig. 67 Spain Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 Key country dynamics
  • Fig. 69 Denmark Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 70 Key country dynamics
  • Fig. 71 Sweden Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 72 Key country dynamics
  • Fig. 73 Norway Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 74 Asia Pacific Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 75 Key country dynamics
  • Fig. 76 Japan Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 77 Key country dynamics
  • Fig. 78 China Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 79 Key country dynamics
  • Fig. 80 India Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 81 Key country dynamics
  • Fig. 82 Thailand Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 83 Key country dynamics
  • Fig. 84 South Korea Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 85 Key country dynamics
  • Fig. 86 Australia Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 87 Latin America Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 88 Key country dynamics
  • Fig. 89 Brazil Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 90 Key country dynamics
  • Fig. 91 Argentina Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 92 MEA Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 93 Key country dynamics
  • Fig. 94 South Africa Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 95 Key country dynamics
  • Fig. 96 Saudi Arabia Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 97 Key country dynamics
  • Fig. 98 UAE Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 99 Key country dynamics
  • Fig. 100 Kuwait Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 101 Key company categorization
  • Fig. 102 Service heat map analysis
  • Fig. 103 Strategic framework
目次
Product Code: GVR-4-68040-616-6

Large Molecule Drug Discovery Outsourcing Market Summary

The global large molecule drug discovery outsourcing market size was estimated at USD 2.89 billion in 2024 and is projected to reach USD 4.83 billion by 2030, growing at a CAGR of 9.02% from 2025 to 2030. The market is driven by increased demand for biologics and next-generation therapies.

Pharmaceutical companies are increasingly shifting their focus from small molecules to larger biomolecules, including peptides, recombinant proteins, and gene-modifying agents, due to rising demand for biologics. As a result, drug sponsors are actively seeking the services of contract research organizations (CROs) that specialize in drug discovery tailored to these biologics. This trend has led to a rise in outsourcing strategies that emphasize early-phase scientific collaboration and expertise in areas such as bioassay development, structural biology, and functional screening.

Furthermore, emerging trends highlight strategic partnerships between biopharma companies and CROs that focus on innovative platform-based models, which serve to mitigate R&D risks while enhancing the progression of assets. In addition, the demand for outsourcing services is more influenced by the depth of scientific expertise, cost effectiveness, and specialization in therapeutic areas. This has led increasing demand for collaboration with partners who have a strong focus on neurodegenerative diseases, rare disorders, and autoimmune conditions.

Moreover, the global expansion of the market is transforming the landscape, as companies seek biologics innovation hubs in regions like North America and Asia Pacific. In addition, CROs are integrating AI-driven tools, biomarker discovery platforms, and automated screening processes to enhance the accuracy of candidate selection. This combination of scientific advancement, geographical growth, and digital innovation is establishing large molecule discovery outsourcing as a fundamental aspect of modern biologics R&D strategies. Such factors are expected to drive market growth over the estimated time period.

Global Large Molecule Drug Discovery Outsourcing Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global large molecule drug discovery outsourcing market report based on workflow, service, therapeutics area, end-use, and region:

  • Workflow Outlook (Revenue, USD Million, 2018 - 2030)
  • Target Identification & Screening
  • Target Validation & Functional Informatics
  • Lead Identification & Candidate Optimization
  • Preclinical Development
  • Others
  • Service Outlook (Revenue, USD Million, 2018 - 2030)
  • Chemistry Services
  • Biology Services
  • Therapeutics Area Outlook (Revenue, USD Million, 2018 - 2030)
  • Respiratory system
  • Pain and Anesthesia
  • Oncology
  • Ophthalmology
  • Hematology
  • Cardiovascular
  • Endocrine
  • Gastrointestinal
  • Immunomodulation
  • Anti-infective
  • Central Nervous System
  • Dermatology
  • Genitourinary System
  • End-use Outlook (Revenue, USD Million, 2018 - 2030)
  • Pharmaceutical & Biotechnology companies
  • Academic Institutes
  • Regional Outlook (Revenue, USD Million, 2018 - 2030)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Sweden
    • Denmark
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Thailand
    • South Korea
    • Australia
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • Argentina
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Research Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Workflow
    • 1.2.2. Service
    • 1.2.3. Therapeutics Area
    • 1.2.4. End Use
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
    • 1.4.3. Secondary Sources
    • 1.4.4. Primary Research
  • 1.5. Information Or Data Analysis
    • 1.5.1. Data Analysis Models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity Flow Analysis
    • 1.7.2. Parent Market Analysis
  • 1.8. List Of Secondary Sources
  • 1.9. List Of Abbreviations
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Large Molecule Drug Discovery Outsourcing Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Clinical Trials Volume Analysis, (2024)
    • 3.3.1. Total Number Of Clinical Trials By Region
    • 3.3.2. Total Number Of Clinical Trials, By Phase
    • 3.3.3. Total Number Of Clinical Trials, By Study Design
    • 3.3.4. Total Number Of Clinical Trials, By Key Therapeutic Area
  • 3.4. Pricing Model Analysis
  • 3.5. Technology Landscape
  • 3.6. Market Analysis Tools
    • 3.6.1. Porter's Five Force Analysis
    • 3.6.2. PESTEL by SWOT Analysis
    • 3.6.3. COVID-19 Impact Analysis

Chapter 4. Large Molecule Drug Discovery Outsourcing Market: Workflow Estimates & Trend Analysis

  • 4.1. Large Molecule Drug Discovery Outsourcing Market, By Workflow: Segment Dashboard
  • 4.2. Large Molecule Drug Discovery Outsourcing Market, By Workflow: Movement Analysis
  • 4.3. Large Molecule Drug Discovery Outsourcing Market Estimates & Forecasts, By Workflow, 2018 - 2030 (USD Million)
  • 4.4. Target Identification & Screening
    • 4.4.1. Target Identification & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Target Validation & Functional Informatics
    • 4.5.1. Target Validation & Functional Informatics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Lead Identification & Candidate Optimization
    • 4.6.1. Lead Identification & Candidate Optimization Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.7. Preclinical Development
    • 4.7.1. Preclinical Development Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.8. Others
    • 4.8.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Large Molecule Drug Discovery Outsourcing Market: Service Estimates & Trend Analysis

  • 5.1. Large Molecule Drug Discovery Outsourcing Market, By Service: Segment Dashboard
  • 5.2. Large Molecule Drug Discovery Outsourcing Market, By Service: Movement Analysis
  • 5.3. Large Molecule Drug Discovery Outsourcing Market Estimates & Forecasts, By Service, 2018 - 2030 (USD Million)
  • 5.4. Chemistry Services
    • 5.4.1. Chemistry Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Biology Services
    • 5.5.1. Biology Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Large Molecule Drug Discovery Outsourcing Market: Therapeutics Area Estimates & Trend Analysis

  • 6.1. Large Molecule Drug Discovery Outsourcing Market, By Therapeutics Area: Segment Dashboard
  • 6.2. Large Molecule Drug Discovery Outsourcing Market, By Therapeutics Area: Movement Analysis
  • 6.3. Large Molecule Drug Discovery Outsourcing Market Estimates & Forecasts, By Therapeutics Area, 2018 - 2030 (USD Million)
  • 6.4. Respiratory system
    • 6.4.1. Respiratory System Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Pain and Anesthesia
    • 6.5.1. Pain and Anesthesia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Oncology
    • 6.6.1. Oncology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7. Ophthalmology
    • 6.7.1. Ophthalmology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.8. Hematology
    • 6.8.1. Hematology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.9. Cardiovascular
    • 6.9.1. Cardiovascular Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.10. Endocrine
    • 6.10.1. Endocrine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.11. Gastrointestinal
    • 6.11.1. Gastrointestinal Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.12. Immunomodulation
    • 6.12.1. Immunomodulation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.13. Anti-infective
    • 6.13.1. Anti-infective Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.14. Central Nervous System
    • 6.14.1. Central Nervous System Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.15. Dermatology
    • 6.15.1. Dermatology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.16. Genitourinary System
    • 6.16.1. Genitourinary System Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Large Molecule Drug Discovery Outsourcing Market: End Use Estimates & Trend Analysis

  • 7.1. Large Molecule Drug Discovery Outsourcing Market, By End Use: Segment Dashboard
  • 7.2. Large Molecule Drug Discovery Outsourcing Market, By End Use: Movement Analysis
  • 7.3. Large Molecule Drug Discovery Outsourcing Market Estimates & Forecasts, By End Use, 2018 - 2030 (USD Million)
  • 7.4. Pharmaceutical & Biotechnology companies
    • 7.4.1. Pharmaceutical & Biotechnology companies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Academic Institutes
    • 7.5.1. Academic Institutes Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Large Molecule Drug Discovery Outsourcing Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Market Dashboard
  • 8.2. Regional Market Share Analysis, 2024 & 2030
  • 8.3. North America
    • 8.3.1. North America Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.2. U.S
      • 8.3.2.1. Key Country Dynamics
      • 8.3.2.2. Competitive Scenario
      • 8.3.2.3. Regulatory Framework
      • 8.3.2.4. U.S. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.3. Canada
      • 8.3.3.1. Key Country Dynamics
      • 8.3.3.2. Competitive Scenario
      • 8.3.3.3. Regulatory Framework
      • 8.3.3.4. Canada Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.4. Mexico
      • 8.3.4.1. Key Country Dynamics
      • 8.3.4.2. Competitive Scenario
      • 8.3.4.3. Regulatory Framework
      • 8.3.4.4. Mexico Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4. Europe
    • 8.4.1. Europe Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.2. UK
      • 8.4.2.1. Key Country Dynamics
      • 8.4.2.2. Competitive Scenario
      • 8.4.2.3. Regulatory Framework
      • 8.4.2.4. UK Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.3. Germany
      • 8.4.3.1. Key Country Dynamics
      • 8.4.3.2. Competitive Scenario
      • 8.4.3.3. Regulatory Framework
      • 8.4.3.4. Germany Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.4. France
      • 8.4.4.1. Key Country Dynamics
      • 8.4.4.2. Competitive Scenario
      • 8.4.4.3. Regulatory Framework
      • 8.4.4.4. France Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.5. Italy
      • 8.4.5.1. Key Country Dynamics
      • 8.4.5.2. Competitive Scenario
      • 8.4.5.3. Regulatory Framework
      • 8.4.5.4. Italy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.6. Spain
      • 8.4.6.1. Key Country Dynamics
      • 8.4.6.2. Competitive Scenario
      • 8.4.6.3. Regulatory Framework
      • 8.4.6.4. Spain Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.7. Denmark
      • 8.4.7.1. Key Country Dynamics
      • 8.4.7.2. Competitive Scenario
      • 8.4.7.3. Regulatory Framework
      • 8.4.7.4. Denmark Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.8. Sweden
      • 8.4.8.1. Key Country Dynamics
      • 8.4.8.2. Competitive Scenario
      • 8.4.8.3. Regulatory Framework
      • 8.4.8.4. Sweden Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.9. Norway
      • 8.4.9.1. Key Country Dynamics
      • 8.4.9.2. Competitive Scenario
      • 8.4.9.3. Regulatory Framework
      • 8.4.9.4. Norway Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5. Asia Pacific
    • 8.5.1. Asia Pacific Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.2. Japan
      • 8.5.2.1. Key Country Dynamics
      • 8.5.2.2. Competitive Scenario
      • 8.5.2.3. Regulatory Framework
      • 8.5.2.4. Japan Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.3. China
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Competitive Scenario
      • 8.5.3.3. Regulatory Framework
      • 8.5.3.4. China Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.4. India
      • 8.5.4.1. Key Country Dynamics
      • 8.5.4.2. Competitive Scenario
      • 8.5.4.3. Regulatory Framework
      • 8.5.4.4. India Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.5. Thailand
      • 8.5.5.1. Key Country Dynamics
      • 8.5.5.2. Competitive Scenario
      • 8.5.5.3. Regulatory Framework
      • 8.5.5.4. Thailand Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.6. South Korea
      • 8.5.6.1. Key Country Dynamics
      • 8.5.6.2. Competitive Scenario
      • 8.5.6.3. Regulatory Framework
      • 8.5.6.4. South Korea Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.7. Australia
      • 8.5.7.1. Key Country Dynamics
      • 8.5.7.2. Competitive Scenario
      • 8.5.7.3. Regulatory Framework
      • 8.5.7.4. Australia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6. Latin America
    • 8.6.1. Latin America Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.2. Brazil
      • 8.6.2.1. Key Country Dynamics
      • 8.6.2.2. Competitive Scenario
      • 8.6.2.3. Regulatory Framework
      • 8.6.2.4. Brazil Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.3. Argentina
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. Competitive Scenario
      • 8.6.3.3. Regulatory Framework
      • 8.6.3.4. Argentina Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.7. MEA
    • 8.7.1. MEA Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.7.2. South Africa
      • 8.7.2.1. Key Country Dynamics
      • 8.7.2.2. Competitive Scenario
      • 8.7.2.3. Regulatory Framework
      • 8.7.2.4. South Africa Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.7.3. Saudi Arabia
      • 8.7.3.1. Key Country Dynamics
      • 8.7.3.2. Competitive Scenario
      • 8.7.3.3. Regulatory Framework
      • 8.7.3.4. Saudi Arabia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.7.4. UAE
      • 8.7.4.1. Key Country Dynamics
      • 8.7.4.2. Competitive Scenario
      • 8.7.4.3. Regulatory Framework
      • 8.7.4.4. UAE Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.7.5. Kuwait
      • 8.7.5.1. Key Country Dynamics
      • 8.7.5.2. Competitive Scenario
      • 8.7.5.3. Regulatory Framework
      • 8.7.5.4. Kuwait Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Market Participant Categorization
  • 9.2. Company Market Share/Assessment Analysis, 2024
  • 9.3. Company Profiles
    • 9.3.1. Evotec SE
      • 9.3.1.1. Company Overview
      • 9.3.1.2. Financial Performance
      • 9.3.1.3. Service Benchmarking
      • 9.3.1.4. Strategic Initiatives
    • 9.3.2. Charles River Laboratories International, Inc.
      • 9.3.2.1. Company Overview
      • 9.3.2.2. Financial Performance
      • 9.3.2.3. Service Benchmarking
      • 9.3.2.4. Strategic Initiatives
    • 9.3.3. WuXi AppTec
      • 9.3.3.1. Company Overview
      • 9.3.3.2. Financial Performance
      • 9.3.3.3. Service Benchmarking
      • 9.3.3.4. Strategic Initiatives
    • 9.3.4. Laboratory Corporation of America Holdings
      • 9.3.4.1. Company Overview
      • 9.3.4.2. Financial Performance
      • 9.3.4.3. Service Benchmarking
      • 9.3.4.4. Strategic Initiatives
    • 9.3.5. Thermo Fisher Scientific Inc.
      • 9.3.5.1. Company Overview
      • 9.3.5.2. Financial Performance
      • 9.3.5.3. Service Benchmarking
      • 9.3.5.4. Strategic Initiatives
    • 9.3.6. Merck & Co., Inc.
      • 9.3.6.1. Company Overview
      • 9.3.6.2. Financial Performance
      • 9.3.6.3. Service Benchmarking
      • 9.3.6.4. Strategic Initiatives
    • 9.3.7. GenScript Biotech Corporation
      • 9.3.7.1. Company Overview
      • 9.3.7.2. Financial Performance
      • 9.3.7.3. Service Benchmarking
      • 9.3.7.4. Strategic Initiatives
    • 9.3.8. Jubilant Biosys Limited
      • 9.3.8.1. Company Overview
      • 9.3.8.2. Financial Performance
      • 9.3.8.3. Service Benchmarking
      • 9.3.8.4. Strategic Initiatives
    • 9.3.9. Pharmaron Beijing Co., Ltd.
      • 9.3.9.1. Company Overview
      • 9.3.9.2. Financial Performance
      • 9.3.9.3. Service Benchmarking
      • 9.3.9.4. Strategic Initiatives
    • 9.3.10. Syngene International Limited
      • 9.3.10.1. Company Overview
      • 9.3.10.2. Financial Performance
      • 9.3.10.3. Service Benchmarking
      • 9.3.10.4. Strategic Initiatives
    • 9.3.11. Dalton Pharma Services
      • 9.3.11.1. Company Overview
      • 9.3.11.2. Financial Performance
      • 9.3.11.3. Service Benchmarking
      • 9.3.11.4. Strategic Initiatives
    • 9.3.12. Domainex Ltd.
      • 9.3.12.1. Company Overview
      • 9.3.12.2. Financial Performance
      • 9.3.12.3. Service Benchmarking
      • 9.3.12.4. Strategic Initiatives
    • 9.3.13. Eurofins Scientific SE
      • 9.3.13.1. Company Overview
      • 9.3.13.2. Financial Performance
      • 9.3.13.3. Service Benchmarking
      • 9.3.13.4. Strategic Initiatives
    • 9.3.14. QIAGEN N.V.
      • 9.3.14.1. Company Overview
      • 9.3.14.2. Financial Performance
      • 9.3.14.3. Service Benchmarking
      • 9.3.14.4. Strategic Initiatives
    • 9.3.15. TCG Lifesciences Pvt Ltd.
      • 9.3.15.1. Company Overview
      • 9.3.15.2. Financial Performance
      • 9.3.15.3. Service Benchmarking
      • 9.3.15.4. Strategic Initiatives